WallStreetZenWallStreetZen

NASDAQ: NKTR
Nektar Therapeutics Stock Ownership - Who owns Nektar Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Nektar Therapeutics insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jonathan ZalevskyCXO2026-08-18186$71.98
$13.39kSell
Howard W. RobinCEO;Pres2026-08-18418$71.98
$30.09kSell
Jonathan ZalevskyChief RD Officer2026-06-305,681$70.00
$397.67kSell
Howard W. RobinPresident CEO2026-06-175,500$60.81
$334.46kSell
Howard W. RobinPresident CEO2026-06-174,500$61.65
$277.43kSell
Howard W. RobinPresident CEO2026-06-165,303$59.97
$318.02kSell
Howard W. RobinPresident CEO2026-06-164,697$60.71
$285.15kSell
Jonathan ZalevskyChief RD Officer2026-06-155,538$60.71
$336.21kSell
Howard W. RobinPresident CEO2026-05-19444$65.51
$29.09kSell
Jonathan ZalevskyChief RD Officer2026-05-19199$65.51
$13.04kSell

1 of 2

NKTR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NKTR insiders and whales buy or sell their stock.

NKTR Shareholders

What type of owners hold Nektar Therapeutics stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Deep Track Capital LP53.73%18,344,000$1.25BInsider
John Stuart Patton8.74%2,984,703$204.03MInsider
Ajit Gill1.69%578,645$39.56MInsider
Robert Chess0.93%316,267$21.62MInsider
Jillian B. Thomsen0.92%313,497$21.43MInsider
Gil M. Labrucherie0.92%312,905$21.39MInsider
R. Scott Greer0.89%303,574$20.75MInsider
Roy A. Whitfield0.84%287,750$19.67MInsider
John Northcott0.65%223,210$15.26MInsider
John Nicholson0.49%165,703$11.33MInsider

1 of 3

NKTR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NKTR0.11%72.08%Net SellingNet Selling
SLS0.04%5.15%Net Selling
AUPH0.06%14.07%Net BuyingNet Selling
BCRX0.10%15.10%Net SellingNet Buying
GENB0.08%54.28%Net BuyingNet Selling
View Top Biotech Stocks

Nektar Therapeutics Stock Ownership FAQ

Who owns Nektar Therapeutics?

Nektar Therapeutics (NASDAQ: NKTR) is owned by 0.11% institutional shareholders, 72.08% Nektar Therapeutics insiders, and 27.82% retail investors. Deep Track Capital LP is the largest individual Nektar Therapeutics shareholder, owning 18.34M shares representing 53.73% of the company. Deep Track Capital LP's Nektar Therapeutics shares are currently valued at $1.23B.

If you're new to stock investing, here's how to buy Nektar Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.